Member access

4-Traders Homepage  >  Shares  >  SHENZHEN STOCK EXCHANGE  >  Beijing SL Pharmaceutical Co Ltd    002038   CNE000001L31

No quotes available
-- CNY   --.--%
08/20 BEIJING SL PHAR : H1 Net Up 22%
04/28 BEIJING SL PHAR : SL Pharmaceutical 2013 Net Up 20.04%
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Beijing SL Pharmaceutical
Produces and supplies pharmaceutical products

Beijing SL Pharmaceutical Co. Ltd. engages in the development and marketing gene engineering drugs.

Its products include Li Sheng Su, a recombinant human Granulocyte Colony-stimulating Factor (rhG-CSF) injection; Mai Ge Er, a recombinant human Interleukin-11 (rhIL-11) injection; and Xin Ji Er, a recombinant human Ala Interleukin-2 (Ala IL-2) injection.

The company was founded by Ming Bo Xu in December 1994 and is headquartered in Beijing, China.

Number of employees : 637 persons.
Sales per Businesses
20122013Delta
CNY (in Million)%CNY (in Million)%
Biochemical Medicine822.9081.8%981.0284.5% +16.12%
Chemistry Medicine128.9412.8%131.5311.3% +1.97%
Other Service Income55.185.5%35.003% -57.68%
Other--14.231.2%-
Sales per Regions
20122013Delta
CNY (in Million)%CNY (in Million)%
China1,006100%1,161100% +13.33%
Managers
NameAgeSinceTitle
Mingbo Xu, PhD50-Chairman & President
Anjing Lu57-Chairman-Supervisory Board
Wenying Xi51-Chief Financial Officer
Yu Lin Chen69-Director
Xiu Jiang Wen37-Director-Supervisory Board
Qing Jun Ma78-Independent Director
Su Yan Wei, CPA62-Independent Director
Ming Xi Zhang, CPA442007Independent Director
Shujie Liang48-Board Secretary
Yong Bo Wang39-Vice President
Shareholders
NameShares%
Xinxiang State Owned Asset Sup. & Adm. Commssion 96,643,72925.8%
Mingbo Xu, PhD 25,743,5016.86%
China International Fund Management Co., Ltd. 12,095,8893.23%
China Resources SZITIC Trust Co., Ltd. 10,100,0442.69%
E Fund Management Co., Ltd. 8,950,6692.39%
Harvest Fund Management Co., Ltd. 8,661,0372.31%
Bin Wang 5,479,1001.46%
Fortune SG Fund Management Co., Ltd. 5,398,1441.44%
Morgan Stanley Huaxin Fund Management Co., Ltd. 5,051,7951.35%
China Universal Asset Management Co., Ltd. 4,932,5851.32%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
ACTELION LTD
SHANGHAI RAAS BLO..
-
MEDIVATION INC
AGIOS PHARMACEUTI..
RECEPTOS INC
HUALAN BIOLOGICAL..
AVANIR PHARMACEUT..
NPS PHARMACEUTICA..
GENMAB A/S
BEIJING SL PHARMA..
TONGHUA DONGBAO P..
INTERCEPT PHARMAC..
BLUEBIRD BIO INC
MANNKIND CORPORAT..
DYAX CORP.
CLOVIS ONCOLOGY I..
PTC THERAPEUTICS,..
ACORDA THERAPEUTI..
NEUROCRINE BIOSCI..
CHINA BIOLOGIC PR..
Sector Biotechnology & Medical Research
Company contact information
Beijing SL Pharmaceutical Co., Ltd.
9 Zhongyuan Road
Bada High Development District
Beijing 100041

Phone : +86.10.8879.9370
Fax : +86.10.8879.5883
Web : www.slpharm.com.cn
© 2014 Factset   
Dynamic quotes  
ON
| OFF